| Trial Identifier: | D0816C00024 |
| Sponsor: | AstraZeneca |
| Collaborator: |
IQVIA
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc
|
| NCTID:: | NCT03553108 |
| Start Date: | May 2018 |
| Primary Completion Date: | March 2019 |
| Study Completion Date: | July 2020 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Dutch Translation | |
| French Translation | |
| German Translation |
| Country | Location |
|---|---|
| Belgium | Leuven, Belgium, 3000 |
| Belgium | Liège, Belgium, 4000 |
| Belgium | Wilrijk, Belgium, 2610 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company